New drug duo aims to spare bladders in cancer fight
NCT ID NCT07151560
Summary
This study is testing whether a combination of two drugs can effectively treat a specific type of aggressive bladder cancer while allowing patients to keep their bladder. It is for adults with HER2-positive tumors who are not good candidates for standard platinum chemotherapy. The main goal is to see if patients can be cancer-free with their bladder intact one year after this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROLOGY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.